2003
DOI: 10.1016/s0959-8049(03)00371-x
|View full text |Cite
|
Sign up to set email alerts
|

BCA-1, A B-cell chemoattractant signal, is constantly expressed in cutaneous lymphoproliferative B-cell disorders

Abstract: We analysed the immunophenotypic and molecular expression of BCA-1 (B-cell-specific chemokine) and CXCR5 (BCA-1 receptor) in normal skin and different cutaneous lymphoproliferative disorders (cutaneous T-cell lymphoma (CTCL); cutaneous B-cell lymphoma (CBCL); cutaneous B-cell pseudolymphoma (PCBCL)), with the aim of investigating their possible involvement in the pathogenesis of cutaneous B-cell disorders. BCA-1 and CXCR5 were constantly expressed in CBCL and PCBCL, but not in normal skin and CTCL. BCA-1 and C… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0

Year Published

2006
2006
2021
2021

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(14 citation statements)
references
References 30 publications
0
14
0
Order By: Relevance
“…No previous information is available concerning the expression of this molecule in the skin of these patients. At variance from cutaneous lymphoproliferative B-cell disorders, in which CXCL13 was detected as a cellassociated molecule constantly expressed by neoplastic B cells and follicular dendritic cells within lymphoid infiltrates, 42 we established a staining pattern consisting of a diffuse expression of CXCL13 protein in the dermis along collagen bundles. This feature, with variable expression in the different areas of the dermis, paralleled the expression of specific mRNA signal, suggesting that CXCL13 is dependent on up-regulation of CXCL13-producing cells.…”
Section: Discussionmentioning
confidence: 99%
“…No previous information is available concerning the expression of this molecule in the skin of these patients. At variance from cutaneous lymphoproliferative B-cell disorders, in which CXCL13 was detected as a cellassociated molecule constantly expressed by neoplastic B cells and follicular dendritic cells within lymphoid infiltrates, 42 we established a staining pattern consisting of a diffuse expression of CXCL13 protein in the dermis along collagen bundles. This feature, with variable expression in the different areas of the dermis, paralleled the expression of specific mRNA signal, suggesting that CXCL13 is dependent on up-regulation of CXCL13-producing cells.…”
Section: Discussionmentioning
confidence: 99%
“…on May 10, 2018. by guest www.bloodjournal.org From stimulation, in the skin or at other extralymphoid sites such as the stomach mucosa or the orbit, B-cell lymphomas, in particular marginal zone and follicular lymphomas, can eventually arise. [72][73][74] Naive B cells need to recirculate freely through peripheral and mucosal lymphoid tissues to optimize their chances of meeting their cognate antigen, whereas B memory cells and plasmablasts have to migrate to specific lymphoid environments dedicated to their recall and effector functions. Like T cells, B cells consequently must adapt their homing signature to their specific maturational stage (Figure 4).…”
Section: The Dissemination Of B-cell Lymphomasmentioning
confidence: 99%
“…Nevertheless, the expression of none of these markers is specific to AITL as there are reported cases of the expression of PD-1 in adult T-cell leukemia/lymphoma, 61 and of CXCL13 in primary central nervous system lymphoma, 63 mucosa-associated lymphoid tissue gastric lymphomas, 43 and in all cutaneous lymphoproliferative B-cell disorders. 45 Furthermore, it is well known that BCL6 is expressed in many different subtypes of B-cell and T-cell leukemic/lymphoid neoplasms. 35 We investigated CD10 expression in this study because it is also expressed in the neoplastic component of AITL.…”
Section: Several Molecules Known To Be Crucial For Mediating T-cell Hmentioning
confidence: 99%